Assenagon Asset Management
ARNA

Assenagon Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Assenagon Asset Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-126,106
Closed -$11.7M – 1611
2021
Q4 		$11.7M Buy
126,106
+39,878
+46% +$2.63M 0.03% 298
2021
Q3 		$5.13M Sell
86,228
-401,205
-82% -$23.7M 0.02% 433
2021
Q2 		$33.2M Buy
487,433
+375,052
+334% +$24.4M 0.11% 163
2021
Q1 		$7.8M Buy
+112,381
New +$8.65M 0.03% 398
2020
Q4 		– Sell
-87,012
Closed -$6.51M – 1328
2020
Q3 		$6.51M Buy
87,012
+42,152
+94% +$2.81M 0.04% 272
2020
Q2 		$2.82M Buy
+44,860
New +$2.47M 0.02% 486
2020
Q1 		– Sell
-27,250
Closed -$1.24M – 1051
2019
Q4 		$1.24M Buy
+27,250
New +$1.29M 0.01% 538

Assenagon Asset Management's ARNA Position: Q1 2022 in Review

Assenagon Asset Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 126,106 shares — an estimated $11.7M sold.

Assenagon Asset Management first reported a position in ARNA in Q4 2019 and held it in 7 quarters. The position peaked at $33.2M in Q2 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Assenagon Asset Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Assenagon Asset Management sold 126,106 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $11.7M.
  • Assenagon Asset Management first reported a position in Arena Pharmaceuticals Inc in Q4 2019 and held it in 7 quarters.
  • Assenagon Asset Management's Arena Pharmaceuticals Inc position peaked at $33.2M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Assenagon Asset Management's 13F filing for Q1 2022, filed 25 Apr 2022.